M. Jones

Successful targeting of the NRG1 pathway indicates novel treatment strategy for metastatic cancer

E. Pleasance, M. Marra, A. Mungall, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

NRG1 fusion-driven tumors: biology, detection and the therapeutic role of afatinib and other ErbB-targeting agents.

A. Drilon, R. Schlenk, C. Heining, 2020, Annals of oncology : official journal of the European Society for Medical Oncology.

Whole genome and transcriptome analysis enhances precision cancer treatment options.

K. Savage, E. Pleasance, M. Marra, 2022, Annals of oncology : official journal of the European Society for Medical Oncology.

Carcinoma ex pleomorphic adenoma: case report and options for systemic therapy.

M. Marra, K. Kasaian, Cheryl Ho, 2017, Current oncology.

Advances in Brief High Frequency of pià 3 ( CDKN 2 / MTS-1 / INK 4 A ) Inactivation in Head and Neck Squamous Cell Carcinoma 1 ' 2

Wayne, J. Bartek, D. Sidransky, 2006 .

Overexpression of p53 in tall cell variants of papillary thyroid carcinoma.

S. Lennquist, R. Nishiyama, J. Dreifus, 1996, Surgery.

Response to angiotensin blockade with irbesartan in a patient with metastatic colorectal cancer

Richard A. Moore, J. Schein, E. Pleasance, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Immune Activation following Irbesartan Treatment in a Colorectal Cancer Patient: A Case Study

M. Marra, S. Kalloger, A. Mungall, 2023, International journal of molecular sciences.